TW200744635A - Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid - Google Patents

Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid

Info

Publication number
TW200744635A
TW200744635A TW095131667A TW95131667A TW200744635A TW 200744635 A TW200744635 A TW 200744635A TW 095131667 A TW095131667 A TW 095131667A TW 95131667 A TW95131667 A TW 95131667A TW 200744635 A TW200744635 A TW 200744635A
Authority
TW
Taiwan
Prior art keywords
decrease
preventive
disease caused
lacrimal fluid
intended
Prior art date
Application number
TW095131667A
Other languages
English (en)
Inventor
Mamoru Kobayashi
Tetsuya Asari
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of TW200744635A publication Critical patent/TW200744635A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095131667A 2005-08-29 2006-08-29 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid TW200744635A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005247563 2005-08-29

Publications (1)

Publication Number Publication Date
TW200744635A true TW200744635A (en) 2007-12-16

Family

ID=37808722

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095131667A TW200744635A (en) 2005-08-29 2006-08-29 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid

Country Status (14)

Country Link
US (1) US20100197788A9 (zh)
EP (1) EP1938837A4 (zh)
JP (1) JPWO2007026630A1 (zh)
KR (1) KR20080038412A (zh)
CN (1) CN101252952A (zh)
AU (1) AU2006285963A1 (zh)
BR (1) BRPI0615339A2 (zh)
CA (1) CA2619445A1 (zh)
IL (1) IL189620A0 (zh)
NO (1) NO20081550L (zh)
RU (1) RU2008112176A (zh)
TW (1) TW200744635A (zh)
WO (1) WO2007026630A1 (zh)
ZA (1) ZA200801858B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1955707A4 (en) * 2005-11-28 2010-09-01 Kissei Pharmaceutical PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEUROGENIC PAIN
WO2007114315A1 (ja) * 2006-03-30 2007-10-11 Santen Pharmaceutical Co., Ltd. 角結膜障害治療剤
BRPI0807715A2 (pt) * 2007-02-21 2014-06-03 Kissei Pharmaceutical Composição farmacêutica para a prevenção ou o tratamento de doença associada com a redução de lacrimação.
JPWO2010041569A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール化合物
CN102171191A (zh) 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
WO2010118291A2 (en) 2009-04-10 2010-10-14 Auspex Pharmaceuticals, Inc. Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
CA2780453A1 (en) * 2009-12-02 2011-06-09 Bridge Pharma, Inc. Treating xerophthalmia with compounds increasing meibomian gland secretion
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201612165D0 (en) * 2016-07-13 2016-08-24 Atrogi Ab Combinations for the treatment of type 2 diabetes
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5768684A (en) * 1994-03-04 1998-06-16 Motorola, Inc. Method and apparatus for bi-directional power control in a digital communication system
KR980007105A (ko) * 1996-06-28 1998-03-30 김광호 이동국 송신전력 제어방법
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
US6064659A (en) * 1998-07-10 2000-05-16 Motorola, Inc. Method and system for allocating transmit power to subscriber units in a wireless communications system
JP3471662B2 (ja) * 1998-08-28 2003-12-02 松下電器産業株式会社 送受信装置及びその送信電力制御方法
US6311070B1 (en) * 1999-03-22 2001-10-30 Nortel Networks Limited Variable step size for power control bits to protect against power overshoot
EP1045529B1 (en) * 1999-04-12 2006-11-29 Alcatel A method for improving performances of a mobile radiocommunication system using a power control algorithm
US6569903B2 (en) * 1999-12-07 2003-05-27 Rohto Pharmaceutical Co., Ltd. Ophthalmic compositions
KR100324425B1 (ko) * 1999-12-29 2002-02-27 박종섭 Ｃｄｍａ 시스템에서의 기지국 및 이동국간 순방향/역방향링크 전력제어 방법
JP2001268637A (ja) * 2000-03-15 2001-09-28 Nec Corp 移動機及び基地局並びにそれ等を用いた移動通信システム
CA2313290A1 (en) * 2000-06-30 2001-12-30 Frank Van Heeswyk Adaptive rate power control cdma system
US6856644B1 (en) * 2000-10-31 2005-02-15 Motorola, Inc. Method and apparatus for forward link power control bit generation in a spread-spectrum communication system
JP3577021B2 (ja) * 2001-09-12 2004-10-13 埼玉日本電気株式会社 移動局および移動局における電界状態判定方法
BRPI0407386A (pt) 2003-02-14 2006-02-07 Kissei Pharmaceutical Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes

Also Published As

Publication number Publication date
US20100197788A9 (en) 2010-08-05
RU2008112176A (ru) 2009-10-10
CN101252952A (zh) 2008-08-27
CA2619445A1 (en) 2007-03-08
WO2007026630A1 (ja) 2007-03-08
ZA200801858B (en) 2009-07-29
KR20080038412A (ko) 2008-05-06
AU2006285963A1 (en) 2007-03-08
IL189620A0 (en) 2008-06-05
JPWO2007026630A1 (ja) 2009-03-05
NO20081550L (no) 2008-05-28
EP1938837A1 (en) 2008-07-02
EP1938837A4 (en) 2010-07-21
BRPI0615339A2 (pt) 2011-05-17
US20080306160A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
TW200744635A (en) Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
ES2655435T3 (es) Formulación de disolución rápida de cinacalcet
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
CL2007002949A1 (es) Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora;
AR069530A1 (es) Procedimiento para la fabricacion de un derivado de indolinona
PE20070766A1 (es) Polimorfos de la sal benzoato de 2-((6-(3r)-3-amino-1-piperidinil)-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil)metil)benzonitrilo y metodos para usarlos
CY1112398T1 (el) Πυρρολιδινονες υποκατασταθεισες απο κυκλοεξυλιο ως αναστολεις της 11-β-υδροξυστεροειδικης αφυδρογονασης 1
DK2021336T3 (da) 11-beta-hydroxysteroid-dehydrogenase-1-inhibitorer
NZ592533A (en) METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR
DK1585743T3 (da) 2-(H-indazol-6-ylamino)-benzamid forbindelser som protein kinase inhibitorer, nyttige til behandling opthalmiske sygdomme
EA200970067A1 (ru) Агонисты ep2
DK2400950T3 (da) Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
ITMI20052000A1 (it) Compressa gastroresitente a base di butirrato di sodio
RS50720B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
DE602006002769D1 (de) Glaspresser zum Halten eines Brillenglases
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA200801297A1 (ru) Способ снижения уровня постпрандиальной глюкозы
NO20070187L (no) Oralt desintegrerende farmasoytisk preparat omfattende risperidon
EA201200727A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения
EA200801875A1 (ru) Антагонист cd 80
BRPI0614280A2 (pt) atorvastatina sódica cristalina e amorfa
NO20082922L (no) Terapeutisk middel for keratokonjunktive lidelser
TR201007867T2 (tr) Uzatılmış salım sağlayan gliklazid tablet